Cancer Treatment India vs UK Cost: Full 2026 Comparison

Cancer Treatment India vs UK Cost: What You'll Actually Pay

If you're comparing cancer treatment costs between India and the UK, the short answer is this: private cancer care in India typically costs 60–80% less than equivalent private treatment in the UK, while using much of the same technology and following similar clinical protocols. For patients weighing NHS waiting times against private UK costs, that gap is often what tips the decision toward looking abroad.

Here's a detailed, treatment-by-treatment breakdown of what that actually looks like in numbers — along with what drives the price difference in the first place.

Cancer Treatment Cost: India vs UK, Side by Side

Treatment	UK Private Cost	India Cost	Typical Savings
Cancer surgery (tumour removal)	£15,000–£40,000+	£3,500–£9,000	60–80%
Robotic-assisted surgery	£25,000+	£6,000–£12,000	60–75%
Chemotherapy (per cycle)	£2,500–£6,000	£400–£2,000	60–75%
Radiotherapy (full course)	£10,000–£20,000	£3,000–£7,000	60–70%
Bone marrow/stem cell transplant	£80,000–£150,000+	£20,000–£40,000	60–75%
Proton beam therapy	£60,000+ (limited access)	£15,000–£30,000	50–70%

These are indicative ranges. Actual cost depends on your cancer type, stage, hospital, room category, and treatment duration — always request a written, itemised estimate before committing to a hospital.

Why Is Cancer Treatment So Much Cheaper in India?

The cost gap isn't a quality gap — it comes down to structural differences in how each country's healthcare system operates:

• Lower operational costs. Hospital staffing, real estate, and administrative overheads are significantly lower in India, and those savings pass through to treatment pricing.
• Government-subsidised institutions. Hospitals like Tata Memorial and AIIMS receive public funding, which keeps prices low even for advanced treatment.
• Competitive private healthcare market. With multiple large hospital networks (Apollo, Max, Fortis, Medanta, HCG) competing for both domestic and international patients, package pricing stays transparent and competitive.
• Lower drug and consumable costs. Many cancer drugs and medical consumables are manufactured domestically in India, reducing import and distribution costs compared to the UK.
• No currency-driven overhead. UK private healthcare pricing reflects NHS-adjacent staffing costs and higher consultant fees, which don't scale down the way they do in India's private hospital market.

None of this means Indian hospitals cut corners. Leading centres hold the same JCI and NABH accreditation used to benchmark hospital safety internationally, and treat cancer through multidisciplinary tumour boards — the same team-based model followed at top UK and US cancer centres.

NHS Free Care vs UK Private Cost vs India: Which Comparison Matters?

It's worth being clear about what you're actually comparing. The NHS provides cancer treatment free at the point of use, and for many UK patients, that remains the right choice. The cost comparison with India becomes relevant specifically when:

• NHS waiting times are a concern. Nationally, the target to start treatment within 62 days of an urgent referral has not been met since December 2015, and current performance sits well below the 85% target. For time-sensitive cancers, that wait can matter clinically, not just logistically.
• You're already considering UK private treatment. If you're comparing prices at all, you're likely comparing UK private costs — not NHS costs — against India, since NHS treatment itself has no direct fee to offset.
• A specific technology has limited NHS or UK private access. Treatments like proton beam therapy or CAR-T cell therapy may have restricted availability or long lead times in the UK, pushing patients to look at where else it's accessible sooner.

If your only concern is cost and the NHS pathway works within a safe timeframe for your diagnosis, there's no cost advantage to comparing against India — the NHS remains free. The comparison becomes meaningful once private-pay UK treatment, or unacceptable waiting times, are already on the table.

What's Included in an India Treatment Cost Estimate?

Reputable hospitals with international patient programmes typically offer package pricing that bundles several cost components together, rather than itemised billing that adds up unpredictably:

• Surgery or primary treatment (chemotherapy/radiotherapy course)
• Hospital stay for the recommended duration
• Pre-treatment diagnostics and imaging
• Medications during the inpatient stay
• Standard follow-up consultations before discharge

What's usually not included: flights, accommodation for accompanying family, extended stays beyond the estimated duration, and any additional treatment required due to complications. Always ask for these exclusions in writing alongside your cost estimate.

What's Included in an India Treatment Cost Estimate?

Reputable hospitals with international patient programmes typically offer package pricing that bundles several cost components together, rather than itemised billing that adds up unpredictably:

• Surgery or primary treatment (chemotherapy/radiotherapy course)
• Hospital stay for the recommended duration
• Pre-treatment diagnostics and imaging
• Medications during the inpatient stay
• Standard follow-up consultations before discharge

What's usually not included: flights, accommodation for accompanying family, extended stays beyond the estimated duration, and any additional treatment required due to complications. Always ask for these exclusions in writing alongside your cost estimate.

Additional Costs to Budget For

Beyond the hospital bill, budget for flights and medical visa costs, accommodation for yourself and any accompanying family member, local transport, and a contingency fund of 15–25% on top of your estimate for any unexpected extension of care. Even with these extras included, total cost for most UK patients stays well below equivalent private treatment in the UK.

Is Cheaper Treatment in India Actually Worth It?

For patients comparing UK private pricing, the savings are real and well-documented — often 60–80% lower for the same category of treatment, at hospitals holding the same international accreditation standards used in the UK. But cost shouldn't be the only factor. Before deciding, it's worth confirming:

• The hospital's accreditation status (NABH at minimum, ideally JCI)
• Whether your case will go through a multidisciplinary tumour board
• A full written cost estimate, including what could cause it to change
• How follow-up care will be coordinated with your UK GP or oncologist after you return

Getting these answers upfront turns a cost comparison into a genuinely informed treatment decision — not just a cheaper one.